This finding indicates that, similar to its role in the aforementioned cancers (including osteosarcoma, pancreatic cancer, and hepatocellular carcinoma), TBRG4 also modulates the malignant phenotypes of LUAD cells, thereby contributing to the progression of LUAD. Here, TBRG4 is linked to pancreatic neoplasm.